Results 241 to 250 of about 196,305 (346)

NBS for SCID: only early diagnosis will change the overall survival of the disease? [PDF]

Gabriela Assunção Goebel, Luciana Araújo Oliveira Cunha, Fernanda Gontijo Minafra, Jorge Andrade Pinto   +3 more
openalex   +1 more source

Positive Side‐Effects of Psychotherapy: The Influence of Cognitive‐Behavioral Therapy on Self‐Concept in Patients With Panic Disorder

Journal of Clinical Psychology, Volume 82, Issue 2, Page 180-188, February 2026.
ABSTRACT Objective Past studies show a strong association of the self‐concept (SC) and symptom burden for many mental disorders including anxiety disorders. Cognitive behavioral therapy (CBT) is a highly effective treatment for anxiety disorders that has also been shown to improve SC in patients suffering from such.
Vanessa Renner, Julian Duhm, Thomas Lorenz, Peter Joraschky, Katja Petrowski   +4 more
wiley   +1 more source

Mechanistic study of LINC01296 mediating TRIP13 regulation of neuroblastoma progression. [PDF]

Transl Cancer Res
He Y, Fan J, Lin Y, Zheng C, Fang Y.
europepmc   +1 more source

Inhibition of Primary Effusion Lymphoma Engraftment in Scid Mice by Morpholino Oligomers against Early Lytic Genes of Kaposi'S Sarcoma-Associated Herpesvirus

, 2011
Yan‐Jin Zhang, Deendayal Patel, Yuchen Nan, Sumin Fan   +3 more
openalex   +1 more source

Antibody‐Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy

Journal of Extracellular Vesicles, Volume 15, Issue 2, February 2026.
ABSTRACT T cell and NK92 cell‐derived extracellular vesicles or artificial cell‐derived vesicles (ACDVs) exhibit anti‐cancer effects through inherited cytotoxic proteins like perforin and granzyme or transmembrane receptors like FasL and TRAIL. The anti‐cancer potential of artificial T and NK vesicles has been improved by attaching targeting moieties ...
Brijesh Parlekar, David W. Livingstone, Ashley R. Sutherland, Andrés X. Medina, Wendy Bernhard, John DeCoteau, Tays Hernández, Clarence Ronald Geyer   +7 more
wiley   +1 more source

Functional Characterization of an IL2RG Variant, a Case Report of X-Linked T- B + NK + SCID. [PDF]

Immun Inflamm Dis
Assing K, Christensen EB, Dellgren C, Soelberg KK, Fagerberg C, Elle IC, Larsen BD, Grosen D, Booth C, Marquart HV, Masmas TN, Hartling HJ.   +11 more
europepmc   +1 more source

Scid Mice [PDF]

, 2011
openaire   +1 more source

Mapping the landscape of autoimmunity and autoinflammation in inborn errors of immunity: broad distribution with distinct clustering patterns. [PDF]

Front Immunol
Tahiat A, Touri S, Saad-Djaballah A, Hakem S, Fernini F, Aggoune S, Belhadj H, Bendahmane C, Mokrane L, Bencharif Madani T, Benhacine Z, Melzi S, Aboura R, Messaoudi H, Boudiaf H, Ladj MS, Khelifi Touhami T, Taibi L, Zobiri S, Bouhdjila R, Bouzerar Z, Ibsaine O, Kedji L, Yagoubi A, Belbouab R, Boukari R, Smati L, Rosenzweig SD, Bogunovic D, Notarangelo LD, Djenouhat K.   +30 more
europepmc   +1 more source

SCID-Repopulating Cell [PDF]

, 2020
openaire   +1 more source

Rosuvastatin in Combination With Bortezomib Promotes Osteogenesis in Myeloma Bone Disease by Inhibiting the Secretion of CCL3

eJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT Background Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM) and a primary cause of disability in affected patients. Its pathogenesis is driven by an imbalance in bone remodeling, largely attributed to the overexpression of C‐C motif chemokine ligand 3 (CCL3). While both bortezomib and statins have been reported
Fujun Qu, Mingxu Hui, Fan Yang, Bo Huang, Nian Liu, Yuchan He, Xiaotao Wang   +6 more
wiley   +1 more source